Moreover, the latest move has added strength to Philips’ patient monitoring solutions portfolio. Koninklijke Philips N.V. price-consensus-chart | Koninklijke Philips N.V. Quote Apart from the ...

Philips announced that the FDA granted 510(k) clearance for its new detector-based spectral computed tomography (CT) ...

Nick shares his insights on the pressing challenges facing the U.S. healthcare market and how Philips is transforming patient care through advanced data analytics, diagnostics, and remote monitoring.

Amsterdam, the Netherlands – Royal Philips ... solutions to enhance patient care.” The company’s latest technology advancements in diagnostic, interventional and monitoring solutions ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...

Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.

Data from the LCA assessment indicated that the Philips IntelliVue and EarlyVue monitors can help reduce the health system’s patient monitoring carbon footprint by 508 tons of CO2e across all ...

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a ...

Cardiovascular Institute of the South successfully treats first patient in the U.S. using Philips’ innovative laser system, marking a milestone in advancing personalized care for PAD patients ...